Drugs in R and D

Aims & Scope

Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice.

Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.

The Journal includes: Clinical research on new and established drugs; Preclinical research of direct relevance to clinical drug development; Short communications and case study reports that meet the above criteria will also be considered; Reviews may also be considered.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,790.00 EUR. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Auranofin: Repurposing an Old Drug for a Golden New Age

  Citation: 435

  Authors: Christine, Melanie J.

• Immunosuppressive and Anti-Inflammatory Mechanisms of Triptolide, the Principal Active Diterpenoid from the Chinese Medicinal Herb Tripterygium wilfordii Hook. f.

  Citation: 261

  Authors: Daoming, Peter N.

• A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI

  Citation: 249

  Authors: Andy, Revan Kumar, Jörgen, Doron, Anne Marie Lynge, Gordon, Nagamani, Alessandro, Ying Wai, Ardita, Richard, Alexander Ross, Siri Beier, Arjan, Colin

• Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research

  Citation: 242

  Authors: Jaden, Christine

• Clinical and Experimental Applications of Sodium Phenylbutyrate

  Citation: 227

  Authors: Tommaso, Beniamino

• Applications of Metabolomics in Drug Discovery and Development

  Citation: 184

  Authors: David S

• Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus

  Citation: 157

  Authors: P, A A, M U R, Y S N, Naval

• Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects

  Citation: 151

  Authors: Adrian L.

• Lipid Peroxidation and Cataracts

  Citation: 150

  Authors: Mark A, Anatoly I, Valentina N, Igor V, Johan

• Potential Risks of Pharmacy Compounding

  Citation: 142

  Authors: Jennifer, Michael, John, Michael